Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred O Mueck

Showing results (11-20 of 144) with videos related to

Pageof 15
Sort By:
Maturitas|January 23, 2009
Progestogens and target tissues: vascular systemsAlfred O Mueck, Harald Seeger
Menopause (New York, N.Y.)|October 8, 2014
Chinese obstetrician-gynecologists still need more education in menopausal hormone therapyXiangyan Ruan, Alfred O Mueck
Hormone Molecular Biology and Clinical Investigation|August 1, 2018
Choice of progestogen for endometrial protection in combination with transdermal estradiol in menopausal womenAlfred O Mueck, Thomas Römer
Hormone Molecular Biology and Clinical Investigation|August 19, 2018
The choice of progestogen for HRT in menopausal women: breast cancer risk is a major issueXiangyan Ruan, Alfred O Mueck
Arzneimittel-Forschung|March 1, 2003
Smoking, estradiol metabolism and hormone replacement therapyAlfred O Mueck, Harald Seeger
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Benefits and risks during HRT: main safety issue breast cancerAlfred O Mueck, Xiangyan Ruan
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Are estradiol metabolites involved in gynaecological carcinogenesis?Harald Seeger, Alfred O Mueck
Maturitas|July 12, 2015
Oral contraception for women of middle ageXiangyan Ruan, Alfred O Mueck
Menopause (New York, N.Y.)|March 18, 2005
PAI-1 polymorphism and obesity: further evidence for an emerging role of genetic variations and interactions with menopauseAlfred O Mueck, Harald Seeger
Maturitas|August 13, 2014
Systemic progesterone therapy--oral, vaginal, injections and even transdermal?Xiangyan Ruan, Alfred O Mueck
Pageof 15

Showing results (11-20 of 144) with videos related to

Sort By:
Pageof 15
Maturitas|January 23, 2009
Progestogens and target tissues: vascular systemsAlfred O Mueck, Harald Seeger
Menopause (New York, N.Y.)|October 8, 2014
Chinese obstetrician-gynecologists still need more education in menopausal hormone therapyXiangyan Ruan, Alfred O Mueck
Hormone Molecular Biology and Clinical Investigation|August 1, 2018
Choice of progestogen for endometrial protection in combination with transdermal estradiol in menopausal womenAlfred O Mueck, Thomas Römer
Hormone Molecular Biology and Clinical Investigation|August 19, 2018
The choice of progestogen for HRT in menopausal women: breast cancer risk is a major issueXiangyan Ruan, Alfred O Mueck
Arzneimittel-Forschung|March 1, 2003
Smoking, estradiol metabolism and hormone replacement therapyAlfred O Mueck, Harald Seeger
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Benefits and risks during HRT: main safety issue breast cancerAlfred O Mueck, Xiangyan Ruan
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Are estradiol metabolites involved in gynaecological carcinogenesis?Harald Seeger, Alfred O Mueck
Maturitas|July 12, 2015
Oral contraception for women of middle ageXiangyan Ruan, Alfred O Mueck
Menopause (New York, N.Y.)|March 18, 2005
PAI-1 polymorphism and obesity: further evidence for an emerging role of genetic variations and interactions with menopauseAlfred O Mueck, Harald Seeger
Maturitas|August 13, 2014
Systemic progesterone therapy--oral, vaginal, injections and even transdermal?Xiangyan Ruan, Alfred O Mueck
Pageof 15